Drug Res (Stuttg) 2013; 63(02): 90-93
DOI: 10.1055/s-0032-1333227
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Effect of the Treatment with Alpha-Macroglobulin on the Development of Experimental Pancreatitis

V. E. Di Loreto
1   Bone Biology Laboratory, School of Medicine Rosario National University, Rosario, Argentina
,
S. M. Roma
1   Bone Biology Laboratory, School of Medicine Rosario National University, Rosario, Argentina
,
A. Rigalli
1   Bone Biology Laboratory, School of Medicine Rosario National University, Rosario, Argentina
› Author Affiliations
Further Information

Publication History

received 01 August 2012

accepted 11 December 2012

Publication Date:
17 January 2013 (online)

Abstract

Alpha-macroglobulins are proteinase inhibitors. Monofluorophosphate increases alpha-macroglobulin levels in plasma, inducing a higher survival rate and lower pancreatic damage in rats with pancreatitis. The aim of this study was to evaluate the effect of alpha-macroglobulin on the development of pancreatitis. Pancreatitis was surgically induced in Sprague-Dawley rats divided into groups of 16 rats each and ­subjected to the following intravenous treatments for 3 days: Controls: pancreatitis without treatment, Enriched plasma: pancreatitis+­alpha-macroglobulin-enriched plasma, Normal plasma: pancreatitis+plasma with normal levels of alpha-macroglobulin, Saline Solution: pancreatitis+saline solution, Purified alpha-macroglobulin: pancreatitis+purified alpha-macroglobulin. After 14 days pancreatic damage was assessed using a score that measures: edema, fibrin, neutrophils, mononuclear leukocytes, necrosis, vascular congestion, thrombosis, hemorrhage and fibrosis. Pancreatic damage decreased and the percentage of animals with pancreatitis was lower in enriched-plasma and purified alpha-macroglobulin groups. We conclude that the intravenous administration of alpha-macroglobulins causes a reduction in the histological damage produced by pancreatitis.

 
  • References

  • 1 Saluja AK, Steer MLP. Patophysiology of pancreatitis. Role of citokines and other mediators of inflammation. Digestion 1999; 60: 27-33
  • 2 Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001; 164: 162-170
  • 3 Borth W. Alpha-2-macroglobulin, a multifunctional binding protein with targeting characteristics. FABEB J 1992; 6: 3345-3353
  • 4 Sottrup-Jensen L. Alpha-macroglobulins: structure, shape and mechanism of proteinase complex formation. J Biol Chem 1989; 264: 11539-11542
  • 5 Bísaro de Lorenc L, Ramos AM, Sánchez MC et al. Structural evaluation of plasma alpha2-macroglobulin in acute pancreatitis. Clin Chem Lab Med 2005; 43: 1183-1189
  • 6 Seta T, Noguchi Y, Shimada T et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004; 16: 1287-1293
  • 7 Demols A, Deviere J. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines. J Pancreas 2003; 4: 49-57
  • 8 Reginster JY, Felsenberg D, Pavo I et al. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal wonen with low bone mass: a randomized, controlled trial. Osteoporosis Int 2003; 14: 741-749
  • 9 Rigalli A, Esteban L, Pera L et al. Binding of monofluorophosphate to alpha-2-macroglobulin and C3. Calcif Tissue Int 1997; 60: 86-89
  • 10 Di Loreto V, Rigalli A, Cinara L et al. Effect of disodium monofluorphosphate on plasma and blood viscosity in the rat. Clinic Hemorheol Microcirc 2008; 40: 259-265
  • 11 Di Loreto V, Roma SM, Menoyo I et al. Effect of the administration of monofluorophosphate on alpha-macroglobulin levels and clinical course of pancreatitis in rats. Arzneimittelforschung 2008; 58: 136-140
  • 12 Roma SM, Di Loreto V, Rigalli A. Effect of the treatment with monofluorophosphate on survival and pancreatic damage in rats with pancreatitis. Acta Gastroenterol Latinoam 2010; 40: 130-135
  • 13 Guide to the care and use of experimental animal. Volume 1. Olfert ED, Cross BM, McWilliam AA. (eds.). Canadian Council on animal care Guidelines. 1993
  • 14 Sugimoto M, Takada T, Yasuda H. A new experimental pancreatitis by incomplete closed duodenal loop: the influence of pancreatic microcirculation on the development and progression of induced severe pancreatitis in rats. Pancreas 2004; 28: 112-119
  • 15 Lupo M, Di Loreto V, Rigalli A. Substances administration. In: Experimental surgical models in the laboratory rat. Rigalli A, Di Loreto V. (eds.). Boca Ratón, FL: CRC Press, Taylor & Francis Group; 2009: 55-62
  • 16 Rigalli A. Euthanasia. In: Experimental surgical models in the laboratory rat. Rigalli A, Di Loreto V. (eds.). Boca Ratón, FL: CRC Press, Taylor & Francis Group; 2009: 31-32
  • 17 Niederau C, Ferrel L, Grendell J. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotrip and secretin. Gastroenterology 1985; 88: 1192-1204
  • 18 Klöppel G. Acute pancreatitis. Semin Diagn Pathol 2004; 21: 221-226
  • 19 Laemmli VK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 20 Fétaud V, Frossard JL, Farina A et al. Proteomic profiling in an animal model of acute pancreatitis. Proteomics 2008; 8: 3621-3631